Arcadia Biosciences Inc reports results for the quarter ended in December - Earnings Summary

Arcadia Biosciences

30/03/2022 22:01

* Arcadia Biosciences Inc  RKDA.OQ  reported a quarterly
adjusted
loss of 28 cents​​ per share for the quarter ended in December.
The mean expectation of two analysts for the quarter was for a
loss of 30 cents per share.
    * Revenue fell 69.6% to $2.17 million from a year ago; 
analysts
expected $3.33 million. 
    * Arcadia Biosciences Inc's reported EPS for the quarter was
a
loss of 42 cents​.
    * The mean earnings estimate of analysts had risen by
about 6.3%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Arcadia Biosciences Inc shares had risen by 85.6% this
quarter.
    * The company reported a quarterly loss of $9.28 million.
    * Wall Street's median 12-month price target for Arcadia
Biosciences Inc is $5.25 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated March 30 at 09:00 p.m.  ​All
figures in US dollars unless otherwise stated